I picked up this stock in the fall, 2009 when it was @ $9.00. I sold it at $23 last year, despite listening to a guy tell me back then it was going to settle in at +/- $40.00, in the spring.
Originally, my order was scheduled to go in @ $5, but (my luck) DNDN stopped trading for almost 3 hours, due to 'trader irregularities!' The original order did not go through. Had the stock tanked, no doubt it would have gone through.
I again picked up DNDN at $28. At $25, DNDN seemed to receive increased daily volume and options action. Now that it has moved past $30 and has held there, I believe the guy who said it would reach $40, either was lucky or really knew, It may take awhile, but if the drug they are producing (a prostate cancer retardant?), receives FDA approval, it will zoom past $60 almost overnight.
I am not a 'WOW' person, but this may be as close as it gets.
Dendreon has released data from a subsequent trial that shows it met its primary end point for the trial, giving bulls their way and driving the stock to $30 and change - it is now around $28. The company is expecting an FDA decision - and approval - on or near May 1. Analysts peg Provenge sales at around one billion by 2018. The puts the current market cap is $3.25 billion.
DNDN is working to get everything that FDA will require to have their prostate drug approved. Before they ask for drug certification dndn will have the cash,factory and employees ready to start production..
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>
Zacks Top Ten Stocks for 2010 are now available! Last year's buy-and-hold picks generated a +29.6% return! This is one of our least expensive and easiest products to use, and also one of the most profitable! Be one of the first to get this year's picks. Learn more about Zacks Top Ten >>
Rated #1 best-performing stock newsletter over the past 10 years by independent Hulbert Financial Digest. Zacks Elite gives you full access to the power of the Zacks Rank, plus the private, hand picked Focus List, Timely Buys and Growth & Income Portfolios. Start a Free Trial Today >>
With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 26% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Originally, my order was scheduled to go in @ $5, but (my luck) DNDN stopped trading for almost 3 hours, due to 'trader irregularities!' The original order did not go through. Had the stock tanked, no doubt it would have gone through.
I again picked up DNDN at $28. At $25, DNDN seemed to receive increased daily volume and options action. Now that it has moved past $30 and has held there, I believe the guy who said it would reach $40, either was lucky or really knew, It may take awhile, but if the drug they are producing (a prostate cancer retardant?), receives FDA approval, it will zoom past $60 almost overnight.
I am not a 'WOW' person, but this may be as close as it gets.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment